Nanollose Limited (ASX:NC6) Investor Presentation
Nanollose Limited (ASX:NC6) (FRA:N0L) is commercialising scalable technology to create tree-free fibres with minimal environmental impact.
Nanollose Limited (ASX:NC6) (FRA:N0L) is commercialising scalable technology to create tree-free fibres with minimal environmental impact.
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Nanollose Limited (ASX:NC6) Executive Chairman explains the environmentally friendly textile produced by the company for application in the fashion industry.
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has achieved a significant milestone in its technology commercialisation strategy, following the successful completion of its first pilot scale spin of a Nullarbor lyocell fibre.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.